Amresh Hanchate to Cost-Benefit Analysis
This is a "connection" page, showing publications Amresh Hanchate has written about Cost-Benefit Analysis.
Connection Strength
0.058
-
Kapoor A, Shaffer N, Hanchate A, Roberts M, Smith K. Massachusetts Health Reform Cost Less and Was More Effective for Uninsured Individuals With Venous Thromboembolism: A Cost-Effectiveness Analysis. Med Care. 2016 May; 54(5):474-82.
Score: 0.032
-
Chan K, Lai MN, Groessl EJ, Hanchate AD, Wong JB, Clark JA, Asch SM, Gifford AL, Ho SB. Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration. Clin Gastroenterol Hepatol. 2013 Nov; 11(11):1503-10.
Score: 0.026